Moreover, CCL9 increases the levels of phosphorylated protein kinase B (p-PKB) and B-cell lymphoma-2 (Bcl-2) in tumor cells, which promote the survival of newly arriving tumor cells in the PMN (70). This evidence concerns the gene BCL2 and neoplasm.